About Us
Vision & Mission
Our vision is to improve the lives of cancer patients by enhancing the immuno-oncology therapeutics armamentarium. We are committed to developing innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against cancer without genetic modification.
Leadership
Caitlin Kontulis
VP of Finance and Administration
Simon Fricker, Ph.D.
VP of Research
Jim Cardia, Ph.D.
VP of Business Operations
Board of Directors

Robert Bitterman
Chairman

Geert Cauwenbergh, Dr.Med.Sc.
Director

H. Paul Dorman
Director

Robert Ferrara
Director

Jonathan Freeman, Ph.D.
Director

Curtis Lockshin, Ph.D.
Director

Patricia A. Bradford
Director
Scientific Advisory Board

James D. Griffin, M.D.

Rolf Kiessling, M.D., Ph.D.

Pamela Pavco, Ph.D.